Cue Biopharma Free Cash Flow (Quarterly) Analysis

Cue Biopharma Inc (CUE)

1.50 0.00 (0.00%) USD | NASDAQ | Nov 14, 16:00

1.51 +0.01 (+0.67%) Pre-Market: 08:27

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
June 30, 2024	-10.00M
March 31, 2024	-9.839M
December 31, 2023	-10.96M
September 30, 2023	-7.799M
June 30, 2023	-10.37M
March 31, 2023	-10.83M
December 31, 2022	-10.52M
September 30, 2022	-6.949M
June 30, 2022	-12.91M
March 31, 2022	-11.60M
December 31, 2021	-10.65M
September 30, 2021	-6.64M
June 30, 2021	-10.02M
March 31, 2021	-12.44M
December 31, 2020	-7.107M

Date	Value
September 30, 2020	-8.033M
June 30, 2020	-7.005M
March 31, 2020	-10.94M
December 31, 2019	-6.448M
September 30, 2019	-9.225M
June 30, 2019	-6.676M
March 31, 2019	-8.494M
December 31, 2018	-4.018M
September 30, 2018	-6.599M
June 30, 2018	-7.216M
March 31, 2018	-10.43M
December 31, 2017	-1.864M
September 30, 2017	-3.884M
June 30, 2017	-3.578M
March 31, 2017	-4.02M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-12.91M

Minimum

Jun 2022

-6.448M

Maximum

Dec 2019

-9.530M

Average

-10.02M

Median

Jun 2021

Free Cash Flow (Quarterly) Benchmarks